Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Bioavailability of 4-MUST in Healthy Volunteers
NCT06342804Phase 1Recruiting
- Sponsor
- Valenta Pharm
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of 4-MUST in cholecystitis (2 arms), sponsored by Valenta Pharm. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Concentration and 13 more. Started Mar 2024; status: recruiting.
02
Drugs
4-MUST
03
Conditions
cholecystitis
Beyond the preview
Go deeper on NCT06342804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06342804.